Cargando…
Soluble Vegfr3 gene therapy suppresses multi‐organ metastasis in a mouse mammary cancer model
Accumulating evidence on the association of VEGF‐C with lymphangiogenesis and lymph node metastasis implicates lymphatic vessels as a potential target in anti‐cancer therapy. To evaluate whether blocking VEGF‐C and VEGFR‐3 signaling can inhibit multi‐organ metastases, a mouse metastatic mammary canc...
Autores principales: | Shibata, Masa‐Aki, Shibata, Eiko, Tanaka, Yoshihisa, Shiraoka, Chinatsu, Kondo, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419054/ https://www.ncbi.nlm.nih.gov/pubmed/32539229 http://dx.doi.org/10.1111/cas.14531 |
Ejemplares similares
-
The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model
por: Shibata, Masa-Aki, et al.
Publicado: (2010) -
Synthetic α‐mangostin dilaurate strongly suppresses wide‐spectrum organ metastasis in a mouse model of mammary cancer
por: Shibata, Masa‐Aki, et al.
Publicado: (2018) -
Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer
por: Shibata, Masa-Aki, et al.
Publicado: (2010) -
Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in Apoe-Deficient Mice by a Possible M2 Macrophage-Mediated Mechanism
por: Shibata, Masa-Aki, et al.
Publicado: (2019) -
Metastasis Inhibition
por: Shibata, Masa-Aki, et al.
Publicado: (2023)